The Limited Times

Now you can see non-English news...

Xingfu Medicine claims that there is no arrears of construction fees, and it sues the big judgment for late delivery.

2022-12-23T03:18:05.091Z


Xingfu Pharmaceutical was accused of defaulting on the construction fee of the new factory building of the general contractor "Shengbai", which caused "Shengbai" to be unable to pay more than 20 million yuan for the project to several second contractors. Following this Tuesday (20th), dozens of contractor workers went to happiness


Xingfu Pharmaceutical was accused of defaulting on the construction fee of the new factory building of the general contractor "Shengbai", which caused "Shengbai" to be unable to pay more than 20 million yuan in construction costs to several second contractors.

Following the demonstration on Tuesday (20th) in front of Xingfu Pharmaceutical’s factory in Yuen Long Industrial Estate, today (23rd) more than 20 contractors went to the factory to protest. White cloth demonstrations such as "sweat but no food" were held, demanding that Xingfu Medicine pay the end of the project.


Happiness Pharmaceuticals responded to the inquiry of "Hong Kong 01" earlier, stating that during the construction of the Yuen Long factory, it paid the payable project fee to "Shengbai", the main contractor for the construction of the Yuen Long factory, in a timely manner according to the contract, and has not yet defaulted on "Shengbai". Cypress" any amount.

In addition, due to the serious delay of the project, Xingfu Medicine has handed over to a lawyer to recover the loss of "Shengbai" due to the project delay.



However, Mr. Deng, the representative of the second contractor who went to the demonstration, said that he had cooperated with "Shengbai" for many years and had never been dragged by "Shengbai". means".



As for "Shengbai", it also emphasized to this website that it is still owed by Xingfu Pharmaceutical for the project fee. It believes that there are many factors for the project delay, and the responsibility cannot be shifted to one of the parties, or one of the parties should bear the consequences alone.

Today (23rd) more than 20 second contractors went to Xingfu Pharmaceutical's factory in Yuen Long Industrial Estate to demonstrate, demanding that Xingfu Pharmaceutical pay the final balance of the project.

(Provided by Mr. Deng)

↓↓The second contractor recently went to Xingfu Pharmaceutical’s factory in Yuen Long Industrial Estate to demonstrate↓↓


+1

Xingfu Pharmaceutical, a long-established pharmaceutical company with a history of nearly 70 years, purchased the former factory site of the China Dyeing Factory Building in Yuen Long Industrial Estate for 230 million yuan in 2014. The floor area is about 320,000 square feet. Factory (Engineering) Co., Ltd."

However, the second judgment complained that after the completion of the project in 2019, Xingfu Pharmaceutical owed about 40 million yuan to the high judgment "Shengbai" project, which caused "Shengbai" to have not paid more than 20 million yuan to more than a dozen contractors. Metaengineering mantissa.



Happiness Pharmaceuticals replied that during the construction of the Yuen Long plant, the company had paid the due construction fees in due time to the main contractor for the construction of the Yuen Long plant, "Sun Park Construction (Engineering) Co., Ltd." (formerly known as Hsin Cheong Construction Plant) (Engineering) Co., Ltd.), Happiness Medicine has not defaulted on any payment to "Shengbai".

Xingfu Medicine also pointed out that due to the serious delay of the project, it has been handed over to a lawyer to recover the loss of "Shengbai" due to the delay of the project, and has entered the legal process, so it is not convenient to comment further.

Xingfu Medicine mentioned that it has been negotiating with "Shengbai" on the disputed matters, but no results have been reached so far, but any dispute with "Shengbai" is related to the contractual relationship between "Shengbai" and its subcontractors Or the payment issue has nothing to do.

In addition, Happiness Pharmaceuticals pointed out that the company has no contractual or legal relationship with the self-employed subcontractor of the main contractor "Shengbai", so it cannot comment on the payment issue or dispute between "Shengbai" and its subcontractors .

For all untrue and unilateral remarks, or illegal actions, Happiness Medicine reserves the right to pursue legal responsibility.

Xingfu Medicine claims that it has paid off the project fee and sues for late delivery

After checking the information, Xingfu Pharmaceutical issued a summons in January last year, accusing "Fu Qin Insurance (Hong Kong)" and "Shengbai Construction Factory (Engineering) Co., Ltd." of violating the signed deposit, and the content of the guarantee must be properly performed and complied with the relevant project works contract, the total claim amount is approximately HK$54 million.

Afterwards, "Shengbai" submitted a summons to the High Court to stay the legal proceedings for arbitration.

However, on February 5, 2022, "Fu Qin Insurance (Hong Kong)", which was also the defendant before, issued a subpoena against Shengbai Holdings Co., Ltd. "Shengbai" Construction Factory deposited HKD 58.9 million to "Fu Qin" to guarantee the "Shengbai" Construction Factory's proper performance and compliance with the main construction contract of the Yuen Long Factory Development Project.

"Shengbai" is applying to the High Court against "Fu Qin"'s application for summary judgment, which will be heard in December 2022.

The second Writ of Summons belongs to the High Court Litigation No. High Court Construction and Arbitration Litigation No. 6 of 2021 and is related to the first Writ of Summons.

Xingfu Medicine was accused of defaulting on the construction fee of Dajuan Pharmaceutical Factory.

Source: hk1

All news articles on 2022-12-23

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.